HIV News and Research

RSS

Researchers study how brain deficits associated with HIV and cocaine addiction might add up

Researchers with the Del Monte Institute for Neuroscience at the University of Rochester are studying how the brain puts the 'brakes' on behavior. That may be different in individuals recovering from cocaine addiction and who are also HIV-positive.

21 Dec 2021

Identifying a recurring pattern in broadly neutralizing antibodies that can target an epitope on SARS-CoV-2

Interesting research decrypts a recurring sequence in antibodies against severe acute respiratory syndrome 2 (SARS-CoV-2) and identifies it to be a board neutralizing antibody that targets a conserved epitope on the SARS-CoV-2 receptor-binding domain (RBD) of the spike protein.

21 Dec 2021

Computational analysis of the effect of SARS-CoV-2 Omicron variant spike protein mutations

A new study highlights the potential evolutionary trade-off observed in the omicron variant, detailing the dynamics of the protein structure, its interactions, and subsequent effects.

20 Dec 2021

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Eleven months ago, President Joe Biden assumed office during one of the most critical moments of the covid-19 pandemic. Case counts and death rates were shockingly high.

20 Dec 2021

Smartphone apps could help reduce alcohol consumption among college-age drinkers

Smartphone apps to track blood alcohol abound, but until now had little evidence to show they help manage drinking in young adults.

16 Dec 2021

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.

16 Dec 2021

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

A gene that is overexpressed in some aggressive cancers also appears to be key to the excessive cell proliferation that thickens the walls of pulmonary arteries and ultimately causes the right ventricle of the heart to fail, scientists report.

16 Dec 2021

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

A new study determines the ability of individuals with varying exposure to SARS-CoV-2 infection and vaccination, to neutralize SARS- CoV-2 pseudotypes.

16 Dec 2021

Covid shots for kids are scarce — and demand is mixed — in rural Montana

When children ages 5 to 11 were approved for Pfizer's lower-dose pediatric covid-19 vaccine in November, Annie Edwards was eager to get her daughter Hannah, then 5, the shot because of underlying health conditions she has stemming from her premature birth.

16 Dec 2021

How SARS-CoV-2 affects the male reproductive system

Researchers review the potentially harmful consequences on the male reproductive system in COVID-19 patients.

15 Dec 2021

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

New research optimizes methods for the in-planta expression of the recombinant protein corresponding to the Receptor Binding Domain (RBD) subunit of the surface-exposed Spike glycoprotein of SARS-CoV-2.

15 Dec 2021

Study reveals the impact of HIV on COVID-19 disease

A new study found that during the early months of the COVID-19 pandemic people living with HIV were less likely to die from COVID than persons without HIV.

14 Dec 2021

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

14 Dec 2021

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

13 Dec 2021

Hotel-based protective housing minimizes COVID-19 rates in vulnerable homeless population

Persons experiencing homelessness (PEH) who were at high risk of severe COVID-19 were 2.5 times less likely to contract SARS-CoV-2 if they were provided with individual hotel rooms and medical and social support compared to citywide rates in homeless shelters, according to new research from the University of Chicago Medicine, Lawndale Christian Health Center, and the Chicago Department of Public Health.

13 Dec 2021

People with HIV more likely to develop heart failure, study finds

People with HIV are at higher risk of developing heart failure than people without HIV, a new study found.

13 Dec 2021

COVID-19 pandemic may halt two decades of global progress towards Universal Health Coverage

New evidence compiled by the World Health Organization and the World Bank shows that the COVID-19 pandemic is likely to halt two decades of global progress towards Universal Health Coverage.

13 Dec 2021

UTEP to develop new initiative to reduce HIV in people who use drugs in the El Paso-Ciudad Juárez border

The University of Texas at El Paso will develop a sustainable public health intervention to suppress human immunodeficiency virus (HIV) in people who use drugs in the El Paso-Ciudad Juárez border region to help slow the spread of HIV.

11 Dec 2021

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.

10 Dec 2021

Analysis finds substantially more mutations in the omicron SARS-CoV-2 variant

A University of Florida Health researcher has successfully analyzed the many mutations in the omicron variant of the SARS-CoV-2 virus, a crucial step in better understanding the variant's potential threat and ways to combat it.

9 Dec 2021

HIV News and Research

Researchers study how brain deficits associated with HIV and cocaine addiction might add up

Identifying a recurring pattern in broadly neutralizing antibodies that can target an epitope on SARS-CoV-2

Computational analysis of the effect of SARS-CoV-2 Omicron variant spike protein mutations

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Smartphone apps could help reduce alcohol consumption among college-age drinkers

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

Covid shots for kids are scarce — and demand is mixed — in rural Montana

How SARS-CoV-2 affects the male reproductive system

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

Study reveals the impact of HIV on COVID-19 disease

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

Hotel-based protective housing minimizes COVID-19 rates in vulnerable homeless population

People with HIV more likely to develop heart failure, study finds

COVID-19 pandemic may halt two decades of global progress towards Universal Health Coverage

UTEP to develop new initiative to reduce HIV in people who use drugs in the El Paso-Ciudad Juárez border

New insights about COVID-19 vaccination rates among people living with HIV

Analysis finds substantially more mutations in the omicron SARS-CoV-2 variant

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News